Paper688279
Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
Patton TF and 5 others. Cancer Treat Rep, 1978. Cited by 125 papers, by iCite.
Cite this record
ConductScience Library. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Papers, record 688279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688279
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Half-Life | |
| Humans | |
| Infusions, Parenteral | |
| Injections, Intravenous | |
| Protein Binding | |
| Ultracentrifugation |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10970685 | Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10970685 | PubMed |
| 8422664 | Effect of cisplatin upon expression of in vivo immune tumor resistance. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8422664 | PubMed |
| 7497604 | Long-term pharmacokinetic behavior of platinum after cisplatin administration. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497604 | PubMed |
| 7497595 | A phase I trial of 5-day continuous infusion cisplatin and interferon alpha. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497595 | PubMed |
| 7318146 | Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7318146 | PubMed |
| 7272193 | British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7272193 | PubMed |
| 7200547 | [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/7200547 | PubMed |
| 7196299 | Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7196299 | PubMed |
| 7023712 | Dose-dependent pharmacokinetics and cancer chemotherapy. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7023712 | PubMed |
| 6883623 | Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6883623 | PubMed |
| 6791675 | In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6791675 | PubMed |
| 6685578 | Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6685578 | PubMed |
| 6682017 | A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II). | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6682017 | PubMed |
| 6540631 | Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6540631 | PubMed |
| 6391659 | Effect of cis-platinum on human blood monocyte function in vitro. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6391659 | PubMed |
| 6375139 | Intestinal and liver toxicity of antineoplastic drugs. | West J Med | 1984 | https://conductscience.org/library/papers/6375139 | PubMed |
| 6299598 | Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6299598 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 6161715 | Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6161715 | PubMed |
| 6088712 | Chemosensitivity of malignant human brain tumors. Preliminary results. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6088712 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/688279
GET https://conductscience.org/api/papers/v1/688279/cited_by?page=2